BR0207039A - Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso - Google Patents

Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso

Info

Publication number
BR0207039A
BR0207039A BR0207039-1A BR0207039A BR0207039A BR 0207039 A BR0207039 A BR 0207039A BR 0207039 A BR0207039 A BR 0207039A BR 0207039 A BR0207039 A BR 0207039A
Authority
BR
Brazil
Prior art keywords
methods
fusion polypeptides
platelet glycoprotein
alpha fusion
alpha
Prior art date
Application number
BR0207039-1A
Other languages
English (en)
Inventor
Gray D Shaw
Ravindra Kumar
Dianne S Sako
Francis X Sullivan
Tom Mcdonagh
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of BR0207039A publication Critical patent/BR0207039A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"POLIPEPTìDEOS DE FUSãO DA GLICOPROTEìNA IB ALFA PLAQUETáRIA E SEUS MéTODOS DE USO". A presente invenção fornece composições e métodos para tratamento e prevenção de distúrbios vasculares.
BR0207039-1A 2001-02-06 2002-02-06 Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso BR0207039A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26683801P 2001-02-06 2001-02-06
PCT/US2002/003549 WO2002063003A2 (en) 2001-02-06 2002-02-06 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof

Publications (1)

Publication Number Publication Date
BR0207039A true BR0207039A (pt) 2005-05-03

Family

ID=23016192

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207039-1A BR0207039A (pt) 2001-02-06 2002-02-06 Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso

Country Status (16)

Country Link
US (5) US6991796B2 (pt)
EP (1) EP1360292A2 (pt)
KR (1) KR20030074796A (pt)
CN (1) CN100523188C (pt)
AR (1) AR035779A1 (pt)
AU (3) AU2002240287B2 (pt)
BR (1) BR0207039A (pt)
CA (1) CA2437714A1 (pt)
HU (1) HUP0303167A2 (pt)
IL (1) IL157264A0 (pt)
MX (1) MXPA03007010A (pt)
NO (1) NO20033474L (pt)
NZ (1) NZ528037A (pt)
PL (1) PL373052A1 (pt)
WO (1) WO2002063003A2 (pt)
ZA (1) ZA200306229B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
JP2007537710A (ja) * 2003-06-11 2007-12-27 ワイス 血小板糖タンパク質ＩＢα改変体融合ポリペプチドおよびその使用法
JP2005073528A (ja) * 2003-08-28 2005-03-24 Genetics Inst Llc 生物学的系における生物学的組織への血球の接着を阻害する方法、ならびにその方法に使用するための組成物
EP3225633B1 (en) * 2004-05-21 2020-03-25 The UAB Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
US20080015145A1 (en) * 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
DE102007031708A1 (de) * 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
WO2010071934A1 (en) * 2008-12-22 2010-07-01 Baker Idi Heart And Diabetes Institute Holdings Limited Modulation of platelet activation
CN102988983B (zh) * 2011-09-09 2014-06-11 苏州苏大赛尔免疫生物技术有限公司 抗人血小板膜糖蛋白Ibα嵌合抗体药物组合物
WO2013096932A1 (en) * 2011-12-23 2013-06-27 Vasculogics, Inc. Compositions and methods for treatment of thrombosis and prolonging survival of stored platelets
IN2014DN10714A (pt) 2012-06-26 2015-09-04 Ge Healthcare As
EP2919013B1 (de) * 2014-03-11 2016-11-02 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Detektion von Modulatoren der GPIb-Thrombin-Interaktion
CN107340225B (zh) * 2017-07-13 2019-07-05 徐州医科大学 一种基于流式细胞术检测血小板受体GPIba胞外段酶切的方法
UY38092A (es) 2018-02-20 2019-05-31 Solicitante Grifols Diagnostic Solutions Inc COMPOSICIÓN QUE COMPRENDE UNA PROTEÍNA RECOMBINANTE RECEPTORA GPIba

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
IL88308A0 (en) 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5516964A (en) * 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
JP3735921B2 (ja) * 1996-02-07 2006-01-18 三菱ウェルファーマ株式会社 ＧＰＩｂ・脂質複合体およびその用途
JP2002510481A (ja) * 1998-04-02 2002-04-09 ジェネンテック・インコーポレーテッド 抗体変異体及びその断片
EP1074564B1 (en) * 1998-04-23 2008-12-10 Ajinomoto Co., Inc. Substance with antithrombotic activity and method for detecting glycokallidin
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
US6878881B1 (en) * 2004-09-08 2005-04-12 Stephen K. Henry Modular cable protector assembly

Also Published As

Publication number Publication date
ZA200306229B (en) 2005-05-26
WO2002063003A3 (en) 2003-05-15
AU2006241373A1 (en) 2006-12-14
US20090148427A1 (en) 2009-06-11
US20060140935A1 (en) 2006-06-29
AR035779A1 (es) 2004-07-14
IL157264A0 (en) 2004-02-19
NO20033474D0 (no) 2003-08-05
EP1360292A2 (en) 2003-11-12
NZ528037A (en) 2006-08-31
KR20030074796A (ko) 2003-09-19
MXPA03007010A (es) 2004-07-08
US7049128B2 (en) 2006-05-23
CN1553955A (zh) 2004-12-08
WO2002063003A2 (en) 2002-08-15
US20030232047A1 (en) 2003-12-18
CN100523188C (zh) 2009-08-05
HUP0303167A2 (hu) 2003-12-29
NO20033474L (no) 2003-10-02
CA2437714A1 (en) 2002-08-15
AU2011200943A1 (en) 2011-03-24
US6991796B2 (en) 2006-01-31
US20030091576A1 (en) 2003-05-15
AU2002240287B2 (en) 2006-08-24
US20060093614A1 (en) 2006-05-04
PL373052A1 (en) 2005-08-08

Similar Documents

Publication Publication Date Title
BR0207039A (pt) Polipeptìdeos de fusão da glicoproteìna ib alfa plaquetária e seus métodos de uso
PT1132403E (pt) Peptidos inibidores de tgf g beta1
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
BR0211187A (pt) Composição que contém um peptìdeo e um pigmento e o uso da mesma no escurecimento da pele
DE69905170T2 (de) Thiazolopyrimidinderivate
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
ES2216630T3 (es) Metodos de tratar la hipertension dependiente de la sal.
ATE237321T1 (de) 20-hete antagonisten und agonisten
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69840415D1 (de) Haemasterlin analoge
BRPI0411289A (pt) polipeptìdeos de fusão da variante da glicoproteìna ib alfa de plaquetas e métodos do seu uso
SE9802937D0 (sv) Novel compounds
BR0016524A (pt) Suspensão compreendendo oxcarbazepina
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
ECSP045075A (es) Endoprotesis vasculares ("stents")"
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2171405T3 (es) Resinas de poliuretano ionicas y no ionicas modificadas con poliamina dispersables en agua utilizables en composiciones de revestimiento.
PT853959E (pt) Composicao para o tratamento do amianto
ATE361931T1 (de) N1 modifizierte glycopeptide
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
NO20002408D0 (no) 5-HT1F antagonister
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
MA27140A1 (fr) Les oligopeptides et les compositions qui les contiennent en tant qu'inhibiteurs de cathepsin s
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.